We are live on ! Find out more
PHS

PFM Health Sciences Portfolio holdings

AUM $1.1B
1-Year Est. Return 57.92%
This Fund
S&P 500
This Quarter Est. Return
+4.25%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$4.34B
AUM Growth
-$657M
Cap. Flow
-$485M
Cap. Flow %
-11.17%
Top 10 Hldgs %
42.98%
Holding
79
New
16
Increased
24
Reduced
23
Closed
15

Top Buys

Rank Stock Value
1
BIDU icon
Baidu
BIDU
+$94.7M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$93M
3
BHC icon
Bausch Health
BHC
+$72.6M
4
CPAY icon
Corpay
CPAY
+$65.7M
5
VMC icon
Vulcan Materials
VMC
+$64.8M

Top Sells

Rank Stock Value
1
WBA
Walgreens Boots Alliance
WBA
+$185M
2
AGN
Allergan Inc
AGN
+$144M
3
MCK icon
McKesson
MCK
+$132M
4
BKNG icon
Booking.com
BKNG
+$130M
5
MDVN
MEDIVATION, INC.
MDVN
+$98.6M

Sector Composition

Rank Sector Weight
1 Healthcare 33.04%
2 Communication Services 18.99%
3 Materials 9.44%
4 Technology 8.93%
5 Energy 5.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BRKR icon
51
Bruker
BRKR
$9.54B
$11.3M 0.26%
608,686
-7,934
-1% -$170K
MRK icon
52
Merck
MRK
$322B
$11.2M 0.26%
+198,816
New +$11.2M
MOH icon
53
Molina Healthcare
MOH
$10.5B
$11.2M 0.26%
264,314
-161,888
-38% -$7.16M
ARAV
54
DELISTED
Aravive, Inc. Common Stock
ARAV
$10.4M 0.24%
91,040
+28,135
+45% +$3.73M
RVNC
55
DELISTED
Revance Therapeutics, Inc.
RVNC
$7.51M 0.17%
388,467
+152,605
+65% +$3.98M
AGIO icon
56
Agios Pharmaceuticals
AGIO
$2.09B
$6.64M 0.15%
+108,241
New +$4.67M
CNC icon
57
Centene
CNC
$31.2B
$6.26M 0.14%
+302,676
New +$5.83M
EIGR
58
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$6.1M 0.14%
1,295
+412
+47% +$2.18M
CELG
59
DELISTED
Celgene Corp
CELG
$1.61M 0.04%
+16,956
New +$1.53M
BLUE
60
DELISTED
bluebird bio
BLUE
$1.57M 0.04%
+3,389
New +$1.56M
MRK icon
61
CALL
Merck
MRK
$322B
$917K 0.02%
+956,510
New +$53.7M
BMY icon
62
PUT
Bristol-Myers Squibb
BMY
$130B
$496K 0.01%
+833,500
New +$41.6M
WYNN icon
63
CALL
Wynn Resorts
WYNN
$10.2B
$364K 0.01%
+1,161,500
New +$229M
AAP icon
64
Advance Auto Parts
AAP
$3.47B
– –
-707,241
Closed -$95.4M
AXP icon
65
American Express
AXP
$225B
– –
-790,506
Closed -$75M
BKNG icon
66
Booking.com
BKNG
$155B
– –
-2,696,200
Closed -$130M
NOW icon
67
ServiceNow
NOW
$118B
– –
-3,859,175
Closed -$47.8M
PARA
68
DELISTED
Paramount Global Class B
PARA
– –
-756,160
Closed -$47M
SBUX icon
69
Starbucks
SBUX
$118B
– –
-2,062,802
Closed -$79.8M
TEX icon
70
Terex
TEX
$7.43B
– –
-993,461
Closed -$40.8M
TMO icon
71
Thermo Fisher Scientific
TMO
$216B
– –
-178,193
Closed -$21M
VNET
72
VNET Group
VNET
$1.8B
– –
-788,626
Closed -$23.6M
VTRS icon
73
Viatris
VTRS
$20.8B
– –
-149,532
Closed -$7.71M
WBA
74
DELISTED
Walgreens Boots Alliance
WBA
– –
-2,499,165
Closed -$185M
IPXL
75
DELISTED
Impax Laboratories, Inc.
IPXL
– –
-534,228
Closed -$16M
1 2
3
4

Similar funds

DAM
Delta Asset Management Memphis, Tennessee $1.1B AUM 14.89% 1-Year Est. Return
MAM
Mark Asset Management New York $1.1B AUM 43.79% 1-Year Est. Return
LCM
Legato Capital Management San Francisco, California $1.1B AUM 61.65% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return
DAM
DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return
CF
Corebridge Financial Houston, Texas $1.09B AUM 1.85% 1-Year Est. Return
MIA
MMBG Investment Advisors Miami, Florida $1.09B AUM 30.96% 1-Year Est. Return

PFM Health Sciences's Q3 2014 Portfolio in Review

As of Q3 2014, PFM Health Sciences held 79 positions worth $4.34B, down 13% from $5B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

PFM Health Sciences withdrew a net $485M in Q3 2014, closing 15 positions and reducing 23 holdings. Its most notable exit was Walgreens Boots Alliance, an estimated $185M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 38% a quarter earlier, followed by Communication Services and Materials.

Against the trend, PFM Health Sciences opened a new position in Corpay worth $67.8M.

  • PFM Health Sciences's largest Q3 2014 buy was Corpay: 477,040 shares worth $67.8M.
  • PFM Health Sciences added most to Baidu in Q3 2014, an estimated $94.7M increase.
  • PFM Health Sciences's biggest Q3 2014 reduction was Allergan Inc, cutting an estimated $144M.
  • PFM Health Sciences fully exited Walgreens Boots Alliance in Q3 2014, selling an estimated $185M.
  • PFM Health Sciences's ten largest holdings make up 43% of its $4.34B portfolio in Q3 2014.
  • PFM Health Sciences opened 16 new positions and closed 15 in Q3 2014.
  • PFM Health Sciences's portfolio value fell 13% quarter-over-quarter to $4.34B.

Based on PFM Health Sciences's 13F filing for Q3 2014, filed 14 Nov 2014.